[
1. Abd-El-Aziz, A. S., Agatemor, C., Etkin, N., Overy, D. P., Lanteigne, M., McQuillan, K., et al., 2015: Antimicrobial organometallic dendrimers with tunable activity against multidrug-resistant bacteria. Biomacromolecules, 16, 11, 3694‒3703. DOI: 10.1021/acs.biomac.5b01207.
]Open DOISearch in Google Scholar
[
2. Ayub, A., Wettig, S., 2022: An overview of nanotechnologies for drug delivery to the brain. Pharmaceutics, 14, 2. DOI: 10.3390/pharmaceutics14020224.
]Open DOISearch in Google Scholar
[
3. Bahar, A. A., Liu, Z., Totsingan, F., Buitrago, C., Kallen-bach, N., Ren, D., 2015: Synthetic dendrimeric peptide active against biofilm and persister cells of Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol., 99, 19, 8125‒8135. DOI: 10.1007/s00253-015-6645-7.
]Open DOISearch in Google Scholar
[
4. Barichello, T., Generoso, J. S., Simoes, L. R. R., Goularte, J. S., Petronilho, F., Saigal, P., et al., 2016: Role of micro-glial activation in the pathophysiology of bacterial meningitis. Mol. Neurobiol., 53, 3, 1770‒1781. DOI: 10.1007/s120 35-015-9107-4.
]Open DOISearch in Google Scholar
[
5. Bash, M. C., Matthias, K. A., 2017: Antibiotic resistance in Neisseria. In Mayers, D. L., Sobel, D. J., Ouellette, M., Kaye, K. S., Marchaim, D.: Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, Volume 2. Springer Cham., 843‒865.
]Search in Google Scholar
[
6. Borah, N., Gogoi, A., Saikia, J., 2022: Dendrimeric entities as chemical alternatives toward antimicrobial therapy. In Saha, T., Adhikari, M. D., Tiwary, B. K.: Alternatives to Antibiotics: Recent Trends and Future Prospects. Springer, 379‒400.
]Search in Google Scholar
[
7. Caminade, A. M.,Turrin, C. O., 2014: Dendrimers for drug delivery. J. Mater. Chem., 2, 26, 4055‒4066. DOI: 10.1039/c4tb00171k.
]Open DOISearch in Google Scholar
[
8. Coureuil, M., Lécuyer, H., Bourdoulous, S., Nassif, X., 2017: A journey into the brain: insight into how bacterial pathogens cross blood-brain barriers. Nat. Rev. Microbiol., 15, 3, 149‒159. DOI: 10.1038/nrmicro.2016.178.
]Open DOISearch in Google Scholar
[
9. Davis, L. E., 2018: Acute bacterial meningitis. Continuum (Minneap. Minn.), 24, (5 Neuroinfectious Disease), 1264‒1283. DOI: 10.1212/con.0000000000000660.
]Open DOISearch in Google Scholar
[
10. Dodds, D. R., 2017: Antibiotic resistance: A current epilogue. Biochem. Pharmacol., 134, 139‒146. DOI: 10.1016/j.bcp.2016.12.005.
]Open DOISearch in Google Scholar
[
11. Doran, K. S., Fulde, M., Gratz, N., Kim, B. J., Nau, R., Prasadarao, N., et al., 2016: Host-pathogen interactions in bacterial meningitis. Acta Neuropathol., 131, 2, 185‒209. DOI: 10.1007/s00401-015-1531-z.
]Open DOISearch in Google Scholar
[
12. Ekizoğlu, M., 2017: Infectious diseases of the brain. In Gürsoy-Özdemir, Y., Bozdağ-Pehlivan, S., Sekerdag, E.: Nanotechnology Methods for Neurological Diseases and Brain Tumors. Elsevier. 291‒315.
]Search in Google Scholar
[
13. Falanga, A., Del Genio, V.,Galdiero, S., 2021: Peptides and dendrimers: How to combat viral and bacterial infections. Pharmaceutics, 13, 1, 23. DOI: 10.3390/pharmaceutics13010101.
]Open DOISearch in Google Scholar
[
14. Felczak, A., Wrońska, N., Janaszewska, A., Klajnert, B., Bryszewska, M., Appelhans, D., et al., 2012: Antimicrobial activity of poly (propylene imine) dendrimers. New J. Chem., 36, 11, 2215‒2222.
]Search in Google Scholar
[
15. Feng, Y., Zhang, H., Wu, Z., Wang, S., Cao, M., Hu, D., et al., 2014: Streptococcus suis infection: An emerging/reemerging challenge of bacterial infectious diseases ? Virulence, 5, 4, 477‒497. DOI: 10.4161/viru.28595.
]Open DOISearch in Google Scholar
[
16. Flexner, S., 1907: Experimental cerebro-spinal meningitis in monkeys. J. Exp. Med., 9, 2, 142‒167. DOI: 10.1084/jem.9.2.142.
]Open DOISearch in Google Scholar
[
17. Garcia-Gallego, S., Franci, G., Falanga, A., Gomez, R., Folliero, V., Galdiero, S., et al., 2017: Function oriented molecular design: Dendrimers as novel antimicrobials. Molecules, 22, 10. DOI: 10.3390/molecules22101581.
]Open DOISearch in Google Scholar
[
18. Gauro, R., Nandave, M., Jain, V. K., Jain, K., 2021: Advances in dendrimer-mediated targeted drug delivery to the brain. J. Nanopart. Res., 23, 3, 76. DOI: 10.1007/s11051-021-05175-8.
]Open DOISearch in Google Scholar
[
19. Gholami, M., Mohammadi, R., Arzanlou, M., Akbari Dourbash, F., Kouhsari, E., Majidi, G., et al., 2017: In vitro antibacterial activity of poly (amidoamine)-G7 dendrimer. BMC Infect. Dis., 17, 1, 395. DOI: 10.1186/s12879-017-2513-7.
]Open DOISearch in Google Scholar
[
20. Giovan, R. A., Lavender, P. D., 2018: Central nervous system infections. Primary Care, 45, 3, 505. DOI: 10.1016/j.pop.2018.05.007.
]Open DOISearch in Google Scholar
[
21. He, Z. Y., Wei, X. W., Wei, Y. Q., 2017: Recent advances of nanostructures in antimicrobial therapy. In Grumezescu, A. M.: Antimicrobial Nanoarchitectonics: From Synthesis to Applications. 167‒194.
]Search in Google Scholar
[
22. Heckenberg, S. G., Brouwer, M. C., van de Beek, D., 2014: Bacterial meningitis. Handb. Clin. Neurol., 121, 1361‒1375. DOI: 10.1016/b978-0-7020-4088-7.00093-6.
]Open DOISearch in Google Scholar
[
23. Hoffman, O., Weber, R. J., 2009: Pathophysiology and treatment of bacterial meningitis. Ther. Adv. Neurol., 2, 6, 1‒7. DOI: 10.1177/1756285609337975.
]Open DOISearch in Google Scholar
[
24. Holmes, A. M., Heylings, J. R., Wan, K. W., Moss, G. P., 2019: Antimicrobial efficacy and mechanism of action of poly(amidoamine) (PAMAM) dendrimers against opportunistic pathogens. Int. J. Antimicrob. Agents, 53, 4, 500‒507. DOI: 10.1016/j.ijantimicag.2018.12.012.
]Open DOISearch in Google Scholar
[
25. Hou, S., Zhou, C., Liu, Z., Young, A. W., Shi, Z., Ren, D., et al., 2009: Antimicrobial dendrimer active against Esche richiacoli biofilms. Bioorg. Med. Chem. Lett., 19, 18, 5478‒5481. DOI: 10.1016/j.bmcl.2009.07.077.
]Open DOISearch in Google Scholar
[
26. Huang, D., Wu, D., 2018: Biodegradable dendrimers for drug delivery. Mater. Sci. Eng. C Mater. Biol. Appl., 90, 713‒727. DOI: 10.1016/j.msec.2018.03.002.
]Open DOISearch in Google Scholar
[
27. Huang, J., Li, Y. C., Orza, A., Lu, Q., Guo, P., Wang, L. Y., et al., 2016: Magnetic nanoparticle facilitated drug delivery for cancer therapy with targeted and image-guided approaches. Adv. Funct. Mater., 26, 22, 3818‒3836. DOI: 10.1002/adfm.201504185.
]Open DOISearch in Google Scholar
[
28. Chatterjee, A., Modarai, M., Naylor, N. R., Boyd, S. E., Atun, R., Barlow, J., et al., 2018: Quantifying drivers of antibiotic resistance in humans: A systematic review. Lancet Inf. Dis., 18, 12, E368‒E378. DOI: 10.1016/s1473-3099(18)30296-2.
]Open DOISearch in Google Scholar
[
29. Chen, C. Z., Beck-Tan, N. C., Dhurjati, P., van Dyk, T. K., LaRossa, R. A., Cooper, S. L., 2000: Quaternary ammonium functionalized poly(propylene imine) dendrimers as effective antimicrobials: Structure-activity studies. Biomacromolecules, 1, 3, 473‒480. DOI: 10.1021/bm0055495.
]Open DOISearch in Google Scholar
[
30. Chis, A. A., Dobrea, C., Morgovan, C., Arseniu, A. M., Rus, L. L., Butuca, A., et al., 2020: Applications and limitations of dendrimers in biomedicine. Molecules, 25, 17. DOI: 10.3390/molecules25173982.
]Open DOISearch in Google Scholar
[
31. Christaki, E., Marcou, M., Tofarides, A., 2020: Antimicrobial resistance in bacteria: Mechanisms, evolution, and persistence. J. Mol. Evol., 88, 1, 26‒40. DOI: 10.1007/s00239-019-09914-3.
]Open DOISearch in Google Scholar
[
32. Kalhapure, R. S., Suleman, N., Mocktar, C., Seedat, N., Govender, T., 2015: Nanoengineered drug delivery systems for enhancing antibiotic therapy. J. Pharm. Sci., 104, 3, 872‒905. DOI: 10.1002/jps.24298.
]Open DOISearch in Google Scholar
[
33. Kimura, S., Harashima, H., 2020: Current status and challenges associated with CNS-targeted gene delivery across the BBB. Pharmaceutics, 12, 12. DOI: 10.3390/pharmaceutics12121216.
]Open DOISearch in Google Scholar
[
34. Kullberg, B. J., Vrijmoeth, H. D., van de Schoor, F., Hovius, J. W., 2020: Lyme borreliosis: Diagnosis and management. BMJ, 369, m1041. DOI: 10.1136/bmj.m1041.
]Open DOISearch in Google Scholar
[
35. Kumar, L., Verma, S., Vaidya, B., Mehra, N. K., 2017: Nanocarrier-assisted antimicrobial therapy against intracellular pathogens. In Ficai, A., Grumezescu, A. M.: Nanostructures for Antimicrobial Therapy. Elsevier, 293‒324.
]Search in Google Scholar
[
36. Kumar, M., Sarma, D. K., Shubham, S., Kumawat, M., Verma, V., Nina, P. B., et al., 2021: Futuristic non-antibiotic the apies to combat antibiotic resistance: A review. Front. Microbiol., 12. DOI: 10.3389/fmicb.2021.609459.
]Open DOISearch in Google Scholar
[
37. Kumari, P., Luqman, S., Meena, A., 2020: Nanomaterials: A promising tool for drug delivery. In Daima, H. K., Navya, P. N., Ranjan, S., Dasgupta, N., Lichtfouse, E.: Nanoscience in Medicine, 1, 39. 1‒49.
]Search in Google Scholar
[
38. Ladd, E., Sheikhi, A., Li, N., van de Ven, T. G. M., Kakkar, A., 2017: Design and synthesis of dendrimers with facile surface group functionalization, and an evaluation of their bactericidal efficacy. Molecules, 22, 6. DOI: 10.3390/molecules22060868.
]Open DOISearch in Google Scholar
[
39. LaPenna, P. A., Roos, K. L., 2019: Bacterial infections of the central nervous system. Semin. Neurol., 39, 3, 334‒342. DOI: 10.1055/s-0039-1693159.
]Open DOISearch in Google Scholar
[
40. Le Guennec, L., Coureuil, M., Nassif, X., Bourdoulous, S., 2020: Strategies used by bacterial pathogens to cross the blood-brain barrier. Cell Microbiol., 22, 1, e13132. DOI: 10.1111/cmi.13132.
]Open DOISearch in Google Scholar
[
41. Liechti, F. D., Grandgirard, D., Leib, S. L., 2015: Bacterial meningitis: insights into pathogenesis and evaluation of new treatment options: a perspective from experimental studies. Future Microbiol., 10, 7, 1195‒1213. DOI: 10.2217/fmb.15.43.
]Open DOISearch in Google Scholar
[
42. Longmire, M., Choyke, P. L., Kobayashi, H., 2008: Dendrimer-based contrast agents for molecular imaging. Curr. Top. Med. Chem., 8, 14, 1180‒1186. DOI: 10.2174/156802608785 849021.
]Open DOISearch in Google Scholar
[
43. Mhlwatika, Z., Aderibigbe, B. A., 2018: Application of dendrimers for the treatment of infectious diseases. Molecules, 23, 9. DOI: 10.3390/molecules23092205.
]Open DOISearch in Google Scholar
[
44. Mintzer, M. A., Dane, E. L., O’Toole, G. A., Grinstaff, M. W., 2012: Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases. Mol. Pharm., 9, 3, 342‒354. DOI: 10.1021/mp2005033.
]Open DOISearch in Google Scholar
[
45. Morrison, L., Zembower, T. R., 2020: Antimicrobial resistance. Gastrointest. Endosc. Clin. N. Am., 30, 4, 619‒635. DOI: 10.1016/j.giec.2020.06.004.
]Open DOISearch in Google Scholar
[
46. Nau, R., Djukic, M., Spreer, A., Ribes, S., Eiffert, H., 2015: Bacterial meningitis: An update of new treatment options. Expert Rev. Anti. Infect. Ther., 13, 11, 1401‒1423. DOI: 10.1586/14787210.2015.1077700.
]Open DOISearch in Google Scholar
[
47. Nazli, A., He, D. L., Liao, D., Khan, M. Z. I., Huang, C., He, Y., 2022: Strategies and progresses for enhancing targeted antibiotic delivery. Adv. Drug Deliv. Rev., 189, 114502. DOI: 10.1016/j.addr.2022.114502.
]Open DOISearch in Google Scholar
[
48. Nikzamir, M., Hanifehpour, Y., Akbarzadeh, A., Panahi, Y., 2021: Applications of dendrimers in nanomedicine and drug delivery: A review. J. Inorg. Organomet. Polym. Mater., 31, 6, 2246‒2261. DOI: 10.1007/s10904-021-01925-2.
]Open DOISearch in Google Scholar
[
49. Omidi, Y., Kianinejad, N., Kwon, Y., Omidian, H., 2021: Drug delivery and targeting to brain tumors: Considerations for crossing the blood-brain barrier. Expert. Rev. Clin. Pharmacol., 14, 3, 357‒381. DOI: 10.1080/17512433.2021.1887729.
]Open DOISearch in Google Scholar
[
50. Oppenheim, B. A., 1997: Antibiotic resistance in Neisseria meningitidis. Clin. Infect. Dis., 24, S98‒S101. DOI: 10.1093/clinids/24.Supplement_1.S98.
]Open DOISearch in Google Scholar
[
51. Pardon, E., Laeremans, T., Triest, S., Rasmussen, S. G. F., Wohlkonig, A., Ruf, A., et al., 2014: A general protocol for the generation of nanobodies for structural biology. Nature Protocols, 9, 3, 674‒693. DOI: 10.1038/nprot.2014.039.
]Open DOISearch in Google Scholar
[
52. Perry, J., Waglechner, N., Wright, G., 2016: The prehistory of antibiotic resistance. Cold Spring Harb. Perspect., 6, 6. DOI: 10.1101/cshperspect.a025197.
]Open DOISearch in Google Scholar
[
53. Pompilio, A., Geminiani, C., Mantini, P., Siriwardena, T. N., Di Bonaventura, I., Reymond, J. L., et al., 2018: Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies. Infect. Drug Resist., 11, 1767‒1782. DOI: 10.2147/idr.S168868.
]Open DOISearch in Google Scholar
[
54. Pulgar, V. M., 2018: Transcytosis to cross the blood brain barrier, new advancements and challenges. Front. Neurosci., 12, 1019. DOI: 10.3389/fnins.2018.01019.
]Open DOISearch in Google Scholar
[
55. Rabiee, N., Ahmadi, S., Arab, Z., Bagherzadeh, M., Safarkhani, M., Nasseri, B., et al., 2020: Aptamer hybrid nanocomplexes as targeting components for antibiotic/gene delivery systems and diagnostics: A review. Int. J. Nanomed., 15, 4237‒4256. DOI: 10.2147/ijn.S248736.
]Open DOISearch in Google Scholar
[
56. Rajak, B. L., Kumar, R., Gogoi, M., Patra, S., 2020: Antimicrobial activity of nanomaterials. In Daima, H. K., Navya, P. N., Ranjan, S., Dasgupta, N., Lichtfouse, E.: Nano-science in Medicine, 1, 39. 147‒185.
]Search in Google Scholar
[
57. Reygaert, W. C., 2018: An overview of the antimicrobial resistance mechanisms of bacteria. Aims Microbiol., 4, 3, 482‒501. DOI: 10.3934/microbiol.2018.3.482.
]Open DOISearch in Google Scholar
[
58. Rizvi, S. M. D., Hussain, T., Ahmed, A. B. F., Alshammari, T. M., Moin, A., Ahmed, M. Q., et al., 2018: Gold nano-particles: A plausible tool to combat neurological bacterial infections in humans. Biomed. Pharmacother., 107, 7‒18. DOI: 10.1016/j.biopha.2018.07.130.
]Open DOISearch in Google Scholar
[
59. Santos, A., Veiga, F., Figueiras, A., 2020: Dendrimers as pharmaceutical excipients: Synthesis, properties, toxicity and biomedical applications. Materials, 13, 1. DOI: 10.3390/ma13010065.
]Open DOISearch in Google Scholar
[
60. Scorciapino, M. A., Serra, I., Manzo, G., Rinaldi, A. C., 2017: Antimicrobial dendrimeric peptides: Structure, activity and new therapeutic applications. Int. J. Mol. Sci., 18, 3. DOI: 10.3390/ijms18030542.
]Open DOISearch in Google Scholar
[
61. Scheld, W. M., Koedel, U., Nathan, B., Pfister, H. W., 2002: Pathophysiology of bacterial meningitis: Mechanism(s) of neuronal injury. J. Infect. Dis., 186, S225‒S233. DOI: 10.1086/344939.
]Open DOISearch in Google Scholar
[
62. Somani, S., Dufes, C., 2014: Applications of dendrimers for brain delivery and cancer therapy. Nanomedicine, 9, 15, 2403‒2414. DOI: 10.2217/nnm.14.130.
]Open DOISearch in Google Scholar
[
63. Spirescu, V. A., Chircov, C., Grumezescu, A. M., Andronescu, E., 2021: Polymeric nanoparticles for antimicrobial therapies: An up-to-date overview. Polymers, 13, 5. DOI: 10.3390/polym13050724.
]Open DOISearch in Google Scholar
[
64. Stanek, G., Wormser, G. P., Gray, J., Strle, F., 2012: Lyme borreliosis. Lancet, 379, 9814, 461‒473. DOI: 10.1016/s0140-6736(11)60103-7.
]Open DOISearch in Google Scholar
[
65. Staneva, D., Angelova, S., Vasileva-Tonkova, E., Grozdanov, P., Nikolova, I., Grabchev, I., 2020: Synthesis, photophysical characterisation and antimicrobial activity of a new anionic PAMAM dendrimer. J. Photochem. Photobiol., 403, 112878.
]Search in Google Scholar
[
66. Svenningsen, S. W., Frederiksen, R. F., Counil, C., Ficker, M., Leisner, J. J., Christensen, J. B., 2020: Synthesis and antimicrobial properties of a ciprofloxacin and PAMAM-dendrimer conjugate. Molecules, 25, 6. DOI: 10.3390/molecules25061389.
]Open DOISearch in Google Scholar
[
67. Tarach, P., Janaszewska, A., 2021: Recent advances in pre-clinical research using PAMAM dendrimers for cancer gene therapy. Int. J. Mol. Sci., 22, 6. DOI: 10.3390/ijms22062912.
]Open DOISearch in Google Scholar
[
68. Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., et al., 1985: A new class of polymers ‒ star-bust-dendritic macromolecules. Polymer J., 17, 1, 117‒132. DOI: 10.1295/polymj.17.117.
]Open DOISearch in Google Scholar
[
69. van Samkar, A., Brouwer, M. C., Schultsz, C., van der Ende, A., van de Beek, D., 2015: Streptococcus suis meningitis: A systematic review and meta-analysis. PLOS Negl. Trop. Dis., 9, 10, e0004191. DOI: 10.1371/journal.pntd.000 4191.
]Open DOISearch in Google Scholar
[
70. Vega, N. M., Gore, J., 2014: Collective antibiotic resistance: mechanisms and implications. Curr. Opin. Microbiol., 21, 28‒34. DOI: 10.1016/j.mib.2014.09.003.
]Open DOISearch in Google Scholar
[
71. Velasco-Aguirre, C., Morales, F., Gallardo-Toledo, E., Guerrero, S., Giralt, E., Araya, E., et al., 2015: Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches. Int. J. Nanomed., 10, 4919‒4936. DOI: 10.2147/ijn.S82310.
]Open DOISearch in Google Scholar
[
72. Zhu, Y. F., Liu, C. Y., Pang, Z. Q., 2019: Dendrimer-based drug delivery systems for brain targeting. Biomolecules, 9, 12. DOI: 10.3390/biom9120790.
]Open DOISearch in Google Scholar